1: Li Y, Gong P, Hou JX, Huang W, Ma XP, Wang YL, Li J, Cui XB, Li N. miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells. J Immunol Res. 2018 Aug 2;2018:7498514. doi: 10.1155/2018/7498514. eCollection 2018. PubMed PMID: 30175154; PubMed Central PMCID: PMC6098920.
2: Liu K, Yu J, Zhao J, Zhou Y, Xiong N, Xu J, Wang T, Bell RL, Qing H, Lin Z. (AZI2)3'UTR Is a New SLC6A3 Downregulator Associated with an Epistatic Protection Against Substance Use Disorders. Mol Neurobiol. 2018 Jul;55(7):5611-5622. doi: 10.1007/s12035-017-0781-2. Epub 2017 Oct 5. PubMed PMID: 28983843; PubMed Central PMCID: PMC5886844.
3: Fukasaka M, Ori D, Kawagoe T, Uematsu S, Maruyama K, Okazaki T, Kozaki T, Imamura T, Tartey S, Mino T, Satoh T, Akira S, Takeuchi O. Critical role of AZI2 in GM-CSF-induced dendritic cell differentiation. J Immunol. 2013 Jun 1;190(11):5702-11. doi: 10.4049/jimmunol.1203155. Epub 2013 Apr 22. PubMed PMID: 23610142.
4: Gross JA, Fiori LM, Labonté B, Lopez JP, Turecki G. Effects of promoter methylation on increased expression of polyamine biosynthetic genes in suicide. J Psychiatr Res. 2013 Apr;47(4):513-9. doi: 10.1016/j.jpsychires.2012.11.016. Epub 2012 Dec 20. PubMed PMID: 23260169; PubMed Central PMCID: PMC5293536.
5: Fiori LM, Gross JA, Turecki G. Effects of histone modifications on increased expression of polyamine biosynthetic genes in suicide. Int J Neuropsychopharmacol. 2012 Sep;15(8):1161-6. doi: 10.1017/S1461145711001520. Epub 2011 Oct 19. PubMed PMID: 22008221.
6: Murakami Y, Suzuki J, Samejima K, Oka T. Developmental alterations in expression and subcellular localization of antizyme and antizyme inhibitor and their functional importance in the murine mammary gland. Amino Acids. 2010 Feb;38(2):591-601. doi: 10.1007/s00726-009-0422-9. Epub 2009 Dec 8. PubMed PMID: 19997757.
7: Geerts D, Koster J, Albert D, Koomoa DL, Feith DJ, Pegg AE, Volckmann R, Caron H, Versteeg R, Bachmann AS. The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification. Int J Cancer. 2010 May 1;126(9):2012-24. doi: 10.1002/ijc.25074. PubMed PMID: 19960435; PubMed Central PMCID: PMC2847573.
8: Funami K, Sasai M, Ohba Y, Oshiumi H, Seya T, Matsumoto M. Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA. J Immunol. 2007 Nov 15;179(10):6867-72. PubMed PMID: 17982077.
9: Sasai M, Shingai M, Funami K, Yoneyama M, Fujita T, Matsumoto M, Seya T. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol. 2006 Dec 15;177(12):8676-83. PubMed PMID: 17142768.
10: Fujita F, Taniguchi Y, Kato T, Narita Y, Furuya A, Ogawa T, Sakurai H, Joh T, Itoh M, Delhase M, Karin M, Nakanishi M. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol Cell Biol. 2003 Nov;23(21):7780-93. PubMed PMID: 14560022; PubMed Central PMCID: PMC207563.
11: Ivanov IP, Gesteland RF, Atkins JF. A second mammalian antizyme: conservation of programmed ribosomal frameshifting. Genomics. 1998 Sep 1;52(2):119-29. PubMed PMID: 9782076.